dc.contributor.author |
Benli, Erdal |
|
dc.contributor.author |
Gecit, Ilhan |
|
dc.contributor.author |
Gunes, Mustafa |
|
dc.contributor.author |
Kaba, Mehmet |
|
dc.contributor.author |
Kemik, Ahu Sarbay |
|
dc.contributor.author |
Pirincci, Necip |
|
dc.contributor.author |
Tok, Adem |
|
dc.contributor.author |
Yuksel, Mehmet Bilgehan |
|
dc.date.accessioned |
2022-08-17T07:05:44Z |
|
dc.date.available |
2022-08-17T07:05:44Z |
|
dc.date.issued |
2014 |
|
dc.identifier.uri |
http://doi.org/10.7314/APJCP.2014.15.1.381 |
|
dc.identifier.uri |
http://earsiv.odu.edu.tr:8080/xmlui/handle/11489/2685 |
|
dc.description.abstract |
Background: Evidence indicates that Dickkopf-1 (DKK-1) levels may be a biomarker for cancer risk. The aim of this study was to assess DKK-1 and its correlation with clinic-pathological features in patients with bladder cancer. Materials and Methods: DKK-1 levels were determined in serum samples from 90 patients with bladder cancer before transurethral tumor resection. The concentrations of DKK-1 were determined by using enzyme linked immune-sorbent assay (ELISA). Results: Elevated preoperative DKK-1 levels were associated with tumor stage (p<0.001), grade (p<0.001) and histological grade (p<0.001). Conclusions: The results of our study demonstrated that the level of serum DKK-1 is correlated with both disease progression and increase in the tumor grade. Preoperative serum DKK-1 elevation may thus represent a novel marker for the determination of bladder cancer and the detection of patients with a likely poor clinical outcome. |
en_US |
dc.language.iso |
eng |
en_US |
dc.publisher |
ASIAN PACIFIC ORGANIZATION CANCER PREVENTIONAPJCP HEAD OFFICE, KOREAN NATL CANCER CENTER, 323 ILAN -RO, ILSANDONG-GU, GOYANG-SI, GYEONGGI-DO 410-769, SOUTH KOREA |
en_US |
dc.relation.isversionof |
10.7314/APJCP.2014.15.1.381 |
en_US |
dc.rights |
info:eu-repo/semantics/openAccess |
en_US |
dc.subject |
Bladder cancerDKK-1clinic-pathological featuresprognosisTurkey |
en_US |
dc.title |
Dickkopf-1 Levels in Turkish Patients with Bladder Cancer and its Association with Clinicopathological Features |
en_US |
dc.type |
article |
en_US |
dc.relation.journal |
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION |
en_US |
dc.contributor.department |
Ordu Üniversitesi |
en_US |
dc.contributor.authorID |
0000-0001-7329-6971 |
en_US |
dc.contributor.authorID |
0000-0002-5494-0984 |
en_US |
dc.contributor.authorID |
0000-0002-5968-7981 |
en_US |
dc.contributor.authorID |
0000-0003-2044-9086 |
en_US |
dc.identifier.volume |
15 |
en_US |
dc.identifier.issue |
1 |
en_US |
dc.identifier.startpage |
381 |
en_US |
dc.identifier.endpage |
384 |
en_US |